Validation of Patient Reported Outcome Measures for Use in Hallux Valgus
| Status: | Recruiting |
|---|---|
| Conditions: | Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/22/2019 |
| Start Date: | October 30, 2018 |
| End Date: | June 28, 2019 |
| Contact: | Ipsen Recruitment Enquiries |
| Email: | clinical.trials@ipsen.com |
Validation of the Modified Foot Function Index (mFFI) for Use in Hallux Valgus
The purpose of the study is to explore whether the mFFI is fit for purpose in adults with
hallux valgus (HV).
hallux valgus (HV).
Inclusion Criteria:
- Male or female, of any race and, aged ≥ 18 years
- Clinical diagnosis of hallux valgus
- Fluent in reading/speaking US-English to read and understand informed consent form and
to participate in the interview
Exclusion Criteria:
- Participation in another foot-based clinical trial in the last 90 days or in Ipsen's
clinical trial D-FR-52120-237
- Current chronic drug or alcohol abuse problem
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials